New multi-factorial therapies for ataxic cerebral palsy - Al'-Mosawi, Aamir
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Ataxic cerebral palsy is a heterogeneous chronic disabling neurological disorder associated with significant motor impairment. It has a variety of causes including congenital abnormalities, birth asphyxia and kernicterus. It can also be associated with cognitive and visual impairment and abnormal speech. There are no specific therapies, but we have previously reported with use of novel multi-factorial therapies with benefits in patients with ataxic cerebral palsy. The aim of this paper is to describe the use of new multi-factorial therapies in two boys with ataxic cerebral palsy.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Ataxic cerebral palsy is a heterogeneous chronic disabling neurological disorder associated with significant motor impairment. It has a variety of causes including congenital abnormalities, birth asphyxia and kernicterus. It can also be associated with cognitive and visual impairment and abnormal speech. There are no specific therapies, but we have previously reported with use of novel multi-factorial therapies with benefits in patients with ataxic cerebral palsy. The aim of this paper is to describe the use of new multi-factorial therapies in two boys with ataxic cerebral palsy.
Autorenporträt
Aamir Jalal Al-Mosawi è medico consulente presso il Centro nazionale di formazione e sviluppo del Ministero della Salute iracheno e la Città medica di Baghdad. È stato capo della sede irachena del gruppo internazionale di scienziati Copernicus (2006-ottobre 2020). È anche membro del consiglio consultivo dell'Associazione internazionale dei collegi medici (IAMC), dal 2008.